Utah regulators say they’re pushing for new rules governing the presence of delta-8 THC and other synthetic cannabinoids allowed in the state’s medical marijuana supply.
The regulators are reacting after patient advocates, product makers and researchers sounded the alarm over safety concerns in an MMJ market that Utah voters legalized in 2018.
The first medical cannabis pharmacies – as MMJ dispensaries are called in Utah – opened in 2020 after the state Legislature and then-Republican Gov. Gary Hebert made later tweaks.
Those tweaks make Utah an outlier among its more liberal neighbors such as Colorado and Nevada, according to patient advocates and researchers.
Unlike those two states, Utah law currently allows “THC analogs” into edibles, vaporizer cartridges and other products sold in state-licensed pharmacies.
Analogs are defined as “a substance that is structurally or pharmacologically similar to, or is represented as being similar to, delta-9-THC.”
Read full article on Marijuana Business Daily